GPX3 and amyotrophic lateral sclerosis: In ALS cases, an additive and recessive model of GPX3 expression was tested with the risk SNP to suggest lower expression in risk allele carriers (p = 0.12 and p = 0.02, respectively), while for TNIP1 the p-value was n.s. (0.22 and 0.21, respectively).